221 related articles for article (PubMed ID: 28731804)
1. Nuclear Medicine and Molecular Imaging-An Impactful Decade of Contributions to Patient Care and Driving Precision Medicine.
Subramaniam RM
AJR Am J Roentgenol; 2017 Aug; 209(2):241-242. PubMed ID: 28731804
[No Abstract] [Full Text] [Related]
2. Personalized medicine: a new option for nuclear medicine and molecular imaging in the third millennium.
Schillaci O; Urbano N
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):563-566. PubMed ID: 28083691
[No Abstract] [Full Text] [Related]
3. SNMMI Leadership Update: An Exciting Time for Nuclear Medicine and Molecular Imaging.
Schwarz SW
J Nucl Med; 2017 Jun; 58(6):19N. PubMed ID: 28572297
[No Abstract] [Full Text] [Related]
4. Nuclear medicine and anatomic pathology in personalized medicine: a challenging alliance.
Urbano N; Scimeca M; Bonanno E; Schillaci O
Per Med; 2018 Nov; 15(6):457-459. PubMed ID: 30398094
[No Abstract] [Full Text] [Related]
5. Nuclear medicine in the era of personalised medicine.
Lee ST; Scott AM
Intern Med J; 2018 May; 48(5):497-499. PubMed ID: 29722186
[No Abstract] [Full Text] [Related]
6. Radiology and nuclear medicine: advancing together in the era of precision medicine.
Chiti A; Menu Y
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):517-518. PubMed ID: 31938891
[No Abstract] [Full Text] [Related]
7. Nuclear Medicine, Molecular Imaging, and Theranostics: The Future Is Bright.
Czernin J; Calais J
J Nucl Med Technol; 2020 Jun; 48(Suppl 1):82S-83S. PubMed ID: 32605963
[No Abstract] [Full Text] [Related]
8. Bench-to-Bedside Theranostics in Nuclear Medicine.
Jokar N; Assadi M; Yordanova A; Ahmadzadehfar H
Curr Pharm Des; 2020; 26(31):3804-3811. PubMed ID: 32067609
[TBL] [Abstract][Full Text] [Related]
9. Letter from the editors: radionuclide imaging in acute care.
Freeman LM; Blaufox MD
Semin Nucl Med; 2013 Mar; 43(2):69-70. PubMed ID: 23414822
[No Abstract] [Full Text] [Related]
10. Regarding "Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care?".
Wing-Chuen Lam W
J Nucl Med; 2018 Mar; 59(3):545. PubMed ID: 29084825
[No Abstract] [Full Text] [Related]
11. Regarding "Is 16 Months of Specialized Nuclear Medicine Training Enough for Best Patient Care?".
Karam M
J Nucl Med; 2018 Mar; 59(3):545-546. PubMed ID: 29269572
[No Abstract] [Full Text] [Related]
12. [NUCLEAR MEDICINE IN ISRAEL: PAST, PRESENT AND ESPECIALLY THE FUTURE].
Keidar Z
Harefuah; 2021 Jul; 160(7):412-414. PubMed ID: 34263565
[TBL] [Abstract][Full Text] [Related]
13. Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine.
Urbain JL; Scott AM; Lee ST; Buscombe J; Weston C; Hatazawa J; Kinuya S; Singh B; Haidar M; Ross A; Lamoureux F; Kunikowska J; Wadsak W; Dierckx R; Paez D; Giammarile F; Lee KH; O JH; Moshe M; Louw L; More S; Nadel H; Lee D; Wahl R
J Nucl Med; 2023 Jun; 64(6):986-991. PubMed ID: 37142302
[No Abstract] [Full Text] [Related]
14. How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.
Ambrosini V; Carrilho Vaz S; Ahmadi Bidakhvidi N; Chanchou M; Cysouw MCF; Serani F; Voltin CA; Kraeber-Bodere F; Deroose CM; De Geus-Oei LF; Eiber M; Gnanasegaran G; Gotthardt M; Kobe C; Konijnenberg MW; Nanni C; Oprea Lager DE; Rahbar K; Taieb D; Mottaghy FM; Goffin K; Herrmann K
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):3-11. PubMed ID: 37689611
[No Abstract] [Full Text] [Related]
15. Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021.
Pini C; Gelardi F; Sollini M
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3613-3621. PubMed ID: 35870007
[No Abstract] [Full Text] [Related]
16. Digital PET/CT: a new intriguing chance for clinical nuclear medicine and personalized molecular imaging.
Schillaci O; Urbano N
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1222-1225. PubMed ID: 30859431
[No Abstract] [Full Text] [Related]
17. Performance and responsibility guidelines for the nuclear medicine technologist (revision 2003).
;
J Nucl Med Technol; 2003 Dec; 31(4):222-9. PubMed ID: 14657289
[No Abstract] [Full Text] [Related]
18. EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours-the consensus in a nutshell.
Kunikowska J; Ambrosini V; Herrmann K
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1276-1277. PubMed ID: 33624150
[No Abstract] [Full Text] [Related]
19. State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956-2022).
Lan X; Huo L; Li S; Wang J; Cai W
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2455-2461. PubMed ID: 35665836
[No Abstract] [Full Text] [Related]
20. Radionuclide Therapies in Molecular Imaging and Precision Medicine.
Kendi AT; Moncayo VM; Nye JA; Galt JR; Halkar R; Schuster DM
PET Clin; 2017 Jan; 12(1):93-103. PubMed ID: 27863570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
